Literature DB >> 34074985

Hypoglycemia is an early, independent predictor of bacteremia and in-hospital death in patients with cirrhosis.

Yedidya Saiman1, Nadim Mahmud1,2.   

Abstract

BACKGROUND AND AIMS: Bacteremia is a common cause of death in patients with cirrhosis and early antimicrobial therapy can be life-saving. Severe liver disease impairs glucose metabolism such that hypoglycemia may be a presenting sign of infection in patients with cirrhosis. We explored this association using granular retrospective data.
METHODS: We conducted a case-control analysis from 1 January 2008 to 31 December 17 in the University of Pennsylvania Health System. We identified the first blood culture results from all cirrhosis hospitalizations and obtained detailed vital sign and laboratory data in the 24-72 h prior to culture results. We used multivariable logistic regression to develop models predicting blood culture positivity and in-hospital mortality. We repeated these analyses restricted to normothermic individuals. Restricted cubic splines were used to model nonlinearity in the glucose variable.
RESULTS: We identified 1274 cirrhosis admissions with blood culture results (52.7% positive). In adjusted models, minimum glucose 24-72 h prior to blood culture result date was a significant predictor of blood culture positivity. In particular, glucose levels below 100 mg/dL significantly increased the probability of subsequent positive blood culture (e.g. odds ratio 1.89 for 50 mg/dL vs. 100 mg/dL, P = 0.004). This relationship persisted when restricting the cohort to normothermic individuals. Glucose levels <100 mg/dL in patients with bacteremia were also positively associated with in-hospital mortality.
CONCLUSIONS: Early hypoglycemia is predictive of subsequently documented bacteremia and in-hospital mortality in patients with cirrhosis, even among normothermic individuals. In patients without other overt signs of infection, low glucose values may serve as an additional data point to justify early antibiosis.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34074985      PMCID: PMC8669667          DOI: 10.1097/MEG.0000000000002218

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.586


  16 in total

1.  Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Authors:  Satish Garg; Ronald L Brazg; Timothy S Bailey; Bruce A Buckingham; Robert H Slover; David C Klonoff; John Shin; John B Welsh; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2012-02-08       Impact factor: 6.118

2.  The Absence of Fever Is Associated With Higher Mortality and Decreased Antibiotic and IV Fluid Administration in Emergency Department Patients With Suspected Septic Shock.

Authors:  Daniel J Henning; Jeremy R Carey; Kimie Oedorf; Danielle E Day; Colby S Redfield; Colin J Huguenel; Jonathan C Roberts; Leon D Sanchez; Richard E Wolfe; Nathan I Shapiro
Journal:  Crit Care Med       Date:  2017-06       Impact factor: 7.598

3.  Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.

Authors:  Vincent Lo Re; Joseph K Lim; Matthew Bidwell Goetz; Janet Tate; Harini Bathulapalli; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Farah Kidwai; Cynthia Brandt; Zachariah Dorey-Stein; K Rajender Reddy; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-05-27       Impact factor: 2.890

4.  Bacterial translocation of enteric organisms in patients with cirrhosis.

Authors:  I Cirera; T M Bauer; M Navasa; J Vila; L Grande; P Taurá; J Fuster; J C García-Valdecasas; A Lacy; M J Suárez; A Rimola; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

Review 5.  Hypoglycemia, diabetes, and cardiovascular disease.

Authors:  Janet K Snell-Bergeon; R Paul Wadwa
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

6.  Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.

Authors:  D Goldberg; Jd Lewis; Sd Halpern; Mark Weiner; Vincent Lo Re
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-04       Impact factor: 2.890

7.  Hypoglycemia. A common complication of septicemia in cirrhosis.

Authors:  O Nouel; J Bernuau; B Rueff; J P Benhamou
Journal:  Arch Intern Med       Date:  1981-10

8.  Postoperative Blood Glucose Levels Predict Infection After Total Joint Arthroplasty.

Authors:  Michael M Kheir; Timothy L Tan; Matthew Kheir; Mitchell G Maltenfort; Antonia F Chen
Journal:  J Bone Joint Surg Am       Date:  2018-08-15       Impact factor: 5.284

9.  Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records.

Authors:  Mei Lu; Wadih Chacra; David Rabin; Loralee B Rupp; Sheri Trudeau; Jia Li; Stuart C Gordon
Journal:  Clin Epidemiol       Date:  2017-07-12       Impact factor: 4.790

Review 10.  Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes.

Authors:  Chakrapani Balijepalli; Eric Druyts; Gaye Siliman; Michel Joffres; Kristian Thorlund; Edward J Mills
Journal:  Clin Epidemiol       Date:  2017-05-23       Impact factor: 4.790

View more
  1 in total

1.  Hypoglycemia Is Associated With Worse Outcomes in Patients With Cholangitis Despite Undergoing Endoscopic Retrograde Cholangiopancreatography.

Authors:  Adham E Obeidat; Ratib Mahfouz; Kevin Benavente; Landon A Kozai; Mahmoud M Mansour; Mohammad Darweesh; Nikolaos T Pyrsopoulos
Journal:  Cureus       Date:  2022-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.